EUSA Pharma to acquire Janssen Ireland’s Sylvant for $115m
EUSA Pharma has signed a definitive agreement to purchase global rights for Sylvant (siltuximab) drug...
Read More...
Focus:
Close
Close
Close
Go Top
Focus:
EUSA Pharma has signed a definitive agreement to purchase global rights for Sylvant (siltuximab) drug...
Read More...
Go Top